BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
Number Cited Articles
1
Franziska Gaunitz, Sabrina Lehmann, Andreas Thomas, Mario Thevis, Markus A. Rothschild, Katja Mercer-Chalmers-Bender. Post-mortem distribution of the synthetic cannabinoid MDMB-CHMICA and its metabolites in a case of combined drug intoxicationInternational Journal of Legal Medicine 2018; 132(6): 1645 doi: 10.1007/s00414-018-1911-8
2
Amandine Scocard, Amine Benyamina, Sarah Coscas, Laurent Karila. Cannabinoïdes de synthèse : une nouvelle matrice des addictionsLa Presse Médicale 2017; 46(1): 11 doi: 10.1016/j.lpm.2016.11.014
3
Noreen D Mdege, Nick Meader, Charlie Lloyd, Steve Parrott, Jim McCambridge. The Novel Psychoactive Substances in the UK Project: empirical and conceptual review work to produce research recommendationsPublic Health Research 2017; 5(4): 1 doi: 10.3310/phr05040
4
Jeremy T. Goldbach, Ethan H. Mereish, Claire Burgess. Sexual Orientation Disparities in the Use of Emerging DrugsSubstance Use & Misuse 2017; 52(2): 265 doi: 10.1080/10826084.2016.1223691
5
David Hakimian, Orr Tomer, Nurith Hiller, Samuel N. Heyman, Sarah Israel. Fatal Mesenteric Ischemia Induced by Synthetic Cannabinoids: A Case Report and Literature ReviewCase Reports in Emergency Medicine 2017; 2017: 1 doi: 10.1155/2017/6964078
6
Laurent Karila, Amine Benyamina. Cannabis Use Disorders2019; : 169 doi: 10.1007/978-3-319-90365-1_16
7
Andreas K. Breitbarth, Jody Morgan, Alison L. Jones. E-cigarettes—An unintended illicit drug delivery systemDrug and Alcohol Dependence 2018; 192: 98 doi: 10.1016/j.drugalcdep.2018.07.031
8
Ismail Altintop, Cigdem Karakukcu. The Chameleon-Like Properties of Psychoactive Drugs: Examinations with HR LC-MS/MS Technology of Patients Presenting at the Emergency Department Following the Use of Synthetic Cannabinoids: A Case Series and Literature ReviewBehavioral Sciences 2018; 8(10): 88 doi: 10.3390/bs8100088
9
Stephanie Campos, Ellen Benoit, Eloise Dunlap. Risk management strategies of synthetic cannabis usersDrugs and Alcohol Today 2019; 19(4): 270 doi: 10.1108/DAT-04-2019-0012
10
Grażyna Kucharska, Magdalena Filipska, Piotr Adamczyk, Katarzyna Lipiec, Dagmara Roszkowska-Bjanid, Elżbieta Trembecka-Dubel, Maria Szczepańska. Ostre uszkodzenie nerek w przebiegu zatrucia metamfetaminąPediatria Polska 2016; 91(5): 496 doi: 10.1016/j.pepo.2016.06.007
11
Samuel D. Banister, Mitchell Longworth, Richard Kevin, Shivani Sachdev, Marina Santiago, Jordyn Stuart, James B. C. Mack, Michelle Glass, Iain S. McGregor, Mark Connor, Michael Kassiou. Pharmacology of Valinate and tert-Leucinate Synthetic Cannabinoids 5F-AMBICA, 5F-AMB, 5F-ADB, AMB-FUBINACA, MDMB-FUBINACA, MDMB-CHMICA, and Their AnaloguesACS Chemical Neuroscience 2016; 7(9): 1241 doi: 10.1021/acschemneuro.6b00137
12
Martin H. Bluth, Matthew R. Pincus. Narcotic Analgesics and Common Drugs of AbuseClinics in Laboratory Medicine 2016; 36(4): 603 doi: 10.1016/j.cll.2016.07.013
13
Koby Cohen, Aviv Weinstein. The Effects of Cannabinoids on Executive Functions: Evidence from Cannabis and Synthetic Cannabinoids—A Systematic ReviewBrain Sciences 2018; 8(3): 40 doi: 10.3390/brainsci8030040
14
Efrat Kelmer, Jakob A. Shimshoni, Yael Merbl, Ofer Kolski, Sigal Klainbart. Use of gas chromatography–mass spectrometry for definitive diagnosis of synthetic cannabinoid toxicity in a dogJournal of Veterinary Emergency and Critical Care 2019; 29(5): 573 doi: 10.1111/vec.12872
15
Ersin Göl, İsmet Çok. Assessment of types of synthetic cannabinoids in narcotic cases assessed by the Council of Forensic Medicine between 2011–2015, Ankara, TurkeyForensic Science International 2017; 280: 124 doi: 10.1016/j.forsciint.2017.09.017
16
R Le Boisselier, J Alexandre, V Lelong-Boulouard, D Debruyne. Focus on cannabinoids and synthetic cannabinoidsClinical Pharmacology & Therapeutics 2017; 101(2): 220 doi: 10.1002/cpt.563
17
Nozomi Asaoka, Hiroyuki Kawai, Naoya Nishitani, Haruko Kinoshita, Norihiro Shibui, Kazuki Nagayasu, Hisashi Shirakawa, Shuji Kaneko. A new designer drug 5F-ADB activates midbrain dopaminergic neurons but not serotonergic neuronsThe Journal of Toxicological Sciences 2016; 41(6): 813 doi: 10.2131/jts.41.813
18
Yuri P. Springer, Roy Gerona, Erich Scheunemann, Sarah L. Shafer, Thomas Lin, Samuel D. Banister, Michael P. Cooper, Louisa J. Castrodale, Michael Levy, Jay C. Butler, Joseph B. McLaughlin. Increase in Adverse Reactions Associated with Use of Synthetic Cannabinoids — Anchorage, Alaska, 2015–2016MMWR. Morbidity and Mortality Weekly Report 2016; 65(40): 1108 doi: 10.15585/mmwr.mm6540a4
19
Maren Hermanns-Clausen, Dieter Müller, Josephine Kithinji, Verena Angerer, Florian Franz, Florian Eyer, Hartmud Neurath, Gesine Liebetrau, Volker Auwärter. Acute side effects after consumption of the new synthetic cannabinoids AB-CHMINACA and MDMB-CHMICAClinical Toxicology 2018; 56(6): 404 doi: 10.1080/15563650.2017.1393082
20
Eric Rowley, David Benson, Aaron Tiffee, Adam Hockensmith, Henry Zeng, Glenn N. Jones, Mandi W. Musso. Clinical and financial implications of emergency department visits for synthetic marijuanaThe American Journal of Emergency Medicine 2017; 35(10): 1506 doi: 10.1016/j.ajem.2017.04.044
21
Brandon J. Warrick, Anita Paula Tataru, Roy Gerona. New Psychoactive Substances in Pediatric PatientsPediatric Clinics of North America 2017; 64(6): 1223 doi: 10.1016/j.pcl.2017.08.003
22
Mona N. Bahouth, Peggy Kraus, Kathryn Dane, Manuela Plazas Montana, William Tsao, Burton Tabaac, Jagar Jasem, Holly Schmidlin, Evan Einstein, Michael B. Streiff, Satish Shanbhag. Synthetic cannabinoid-associated coagulopathy secondary to long-acting anticoagulant rodenticidesMedicine 2019; 98(36): e17015 doi: 10.1097/MD.0000000000017015
23
Rosheen Mary Grady, Vladimir Belostotsky, Kristen M Hallett, Christina N Grant. A 15-year-old boy with acute onset abdominal pain and hypertensionPaediatrics & Child Health 2017; 22(6): 301 doi: 10.1093/pch/pxx089
24
Aaron J. Roberto, Aileen Lorenzo, Kevin J. Li, Jonathan Young, Abhishek Mohan, Subhash Pinnaka, Kyle A. B. Lapidus. First-Episode of Synthetic Cannabinoid-Induced Psychosis in a Young Adult, Successfully Managed with Hospitalization and RisperidoneCase Reports in Psychiatry 2016; 2016: 1 doi: 10.1155/2016/7257489
25
Jessica V. Rivera, Emily Green Vance, William F. Rushton, Justin K. Arnold. Novel Psychoactive Substances and Trends of AbuseCritical Care Nursing Quarterly 2017; 40(4): 374 doi: 10.1097/CNQ.0000000000000174
26
Timothy W Lefever, Julie A Marusich, Brian F Thomas, Daniel G Barrus, Nicholas C Peiper, Richard C Kevin, Jenny L Wiley. Vaping Synthetic Cannabinoids: A Novel Preclinical Model of E-Cigarette Use in MiceSubstance Abuse: Research and Treatment 2017; 11: 117822181770173 doi: 10.1177/1178221817701739
27
Natalie Thurtle, Rachelle Abouchedid, John R. H. Archer, James Ho, Takahiro Yamamoto, Paul I. Dargan, David M. Wood. Prevalence of Use of Electronic Nicotine Delivery Systems (ENDS) to Vape Recreational Drugs by Club Patrons in South LondonJournal of Medical Toxicology 2017; 13(1): 61 doi: 10.1007/s13181-016-0583-3
28
Gary Sweet, Sara Kim, Samuel Martin, Nicole B. Washington, Nancy Brahm. Psychiatric symptoms and synthetic cannabinoid use: Information for cliniciansMental Health Clinician 2017; 7(4): 156 doi: 10.9740/mhc.2017.07.156
29
Kirsten Elin Smith, Amanda M. Bunting, Michele Staton, Robert Walker, Sara Shalash, Erin Winston, Kevin Pangburn. Examination of Synthetic Cannabinoid and Cathinone Use among a Drug-Using Offender Sample, 2013–2015Journal of Psychoactive Drugs 2017; 49(5): 436 doi: 10.1080/02791072.2017.1361560
30
Miriam Schneider, Chris Maria Friemel, Rupert von Keller, Kristina Adorjan, Udo Bonnet, Alkomiet Hasan, Derik Hermann, Joseph Kambeitz, Dagmar Koethe, Ludwig Kraus, F. Markus Leweke, Beat Lutz, Liane Paul, Oliver Pogarell, Ulrich Preuss, Michael Schäfer, Sophia Schmieder, Roland Simon, Martin Storr, Eva Hoch. Cannabis: Potenzial und Risiko2019; : 65 doi: 10.1007/978-3-662-57291-7_3
31
David D Aguilar, Andrea Giuffrida, Daniel J Lodge. Adolescent Synthetic Cannabinoid Exposure Produces Enduring Changes in Dopamine Neuron Activity in a Rodent Model of Schizophrenia SusceptibilityInternational Journal of Neuropsychopharmacology 2018; 21(4): 393 doi: 10.1093/ijnp/pyy003
32
Léa Hamel-Senecal, Valentin Philippe, Basile Chrétien, Mathilde Lechevrel, Reynald Le Boisselier. Vapoter les drogues, un usage à risquesTherapies 2018; 73(6): 581 doi: 10.1016/j.therap.2018.09.030
33
Brandon J. Bills, Jeffrey Kinkade, Greta Ren, Nicholas E. Manicke. The impacts of paper properties on matrix effects during paper spray mass spectrometry analysis of prescription drugs, fentanyl and synthetic cannabinoidsForensic Chemistry 2018; 11: 15 doi: 10.1016/j.forc.2018.08.002